Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
about
Mu-opioid antagonists for opioid-induced bowel dysfunctionOpioid-induced constipation: advances and clinical guidanceChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesTreatment of opioid-induced gut dysfunction[Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].Opioid antagonists in the treatment of opioid-induced constipation and pruritus.Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesManaging opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Recent advances in the use of opioids for cancer painManagement of opioid-induced gastrointestinal effects in patients receiving palliative care.Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteersMethylnaltrexone in the treatment of opioid-induced constipationDetection of drug effects on gastric emptying and contractility using a wireless motility capsule.Anticipating and treating opioid-associated adverse effects.Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in miceAnalysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer painEfficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.Effects of methylnaltrexone on guinea pig gastrointestinal motility.Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileusEmerging drugs for chronic constipation.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.Opioid-induced constipation: challenges and therapeutic opportunities.Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide.A practical approach to diagnosis and management of functional constipation in adults.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.New treatment options for chronic constipation: mechanisms, efficacy and safety.Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.Methylnaltrexone for the treatment of opioid-induced constipation.Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.Role of gum chewing on the duration of postoperative ileus following ileostomy closure done for typhoid ileal perforation: a prospective randomized trial.Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.Meta-analysis of oro-cecal transit time in fasting subjects.Transcutaneous electrical acupoint stimulation potentiates analgesic effect of morphine.
P2860
Q24243268-E74E635B-D2E7-4012-AA93-8797CF13945EQ26765571-E0A183D7-2DA7-4DFA-AD77-76A327D8D7A7Q28083547-47081BA6-7F8C-46AD-8FB4-A30014B6233EQ28284578-A255E2BE-B0BD-41FA-8410-D18088363525Q31104772-FE3A1253-3163-49C1-B6A6-D4449074BD7FQ31989753-285E512F-6299-4637-9936-2AC673637D17Q33461577-AB721B3D-1DA7-4ABD-A513-E67BEBDCF621Q33593875-372EAC09-74A1-4170-A9BA-C171F5DFBE01Q33715430-D96FB044-EEDD-4D02-A33C-96CAD9A93F62Q33973870-74D85A0C-915B-4A00-B7B8-6225AC7A5181Q34418203-229563BC-67DD-45BF-B2F1-3A555228E19BQ34523889-A8E95EA9-53DD-4AEE-9630-0797D2E9C6EEQ34966995-523327E8-1262-4D7E-BF23-DEF82D347332Q35026245-78812A14-CA0D-4327-8E01-E122D0EBB879Q35079522-D0B1B485-F53B-40DC-89E8-3DF146C7E591Q35194392-DEFE8A77-E746-4FD3-9DBC-9F9F6FEB33B9Q35822213-4C5330AE-7D69-40C5-9812-A0ECD6A62D0BQ36178704-DE843C99-EBBA-49BE-A1F9-2F1212603D56Q36253231-05B230CB-AAED-4C04-AD11-C276938DB489Q36384732-A0306757-35CA-4BFE-B2AB-AC4A682F968FQ36458384-6DE990AE-770D-488A-9428-8E1FA183BD04Q36823204-C8A95451-F782-4AE2-BFE3-521E47B57950Q36854395-F8AB63AD-49DD-4791-8947-093DC4BBE1B3Q36936210-18743D7B-F95D-4365-BA2B-425D4D87CB8DQ37077184-96C49A50-DB22-45F3-B746-8BA7C5605B08Q37570550-4BB51036-608F-4C00-9337-A134164AC877Q37611847-BF98FC4F-0891-4B1D-BD7E-D38261EF12D2Q37846099-9101319D-ED7F-4CC3-A1B7-69032AB6164CQ37916266-FE8F882D-E7EF-4265-A74B-83B7CCC8B222Q37941498-3911EB03-6635-4477-AE6D-9BDB1A8E714BQ37954521-754A4E0C-C7FB-4B1E-88B1-2CAC587B924DQ37960501-9877E5B6-21E8-4C62-9CBA-D60462D8413DQ37993108-37294EFE-F78C-4B9F-8742-0DDD8BD45101Q38069607-632F7FDD-9C25-42F0-A124-8247010255C1Q38123753-FD302079-2001-4BAB-A7F1-D5B555346B41Q40293158-EE912D9F-E17A-4DD0-B2BD-A17BF963829DQ42119682-1B352A3E-61AE-49AD-B3EE-83D82F0B7E3EQ43266400-540A039B-07D0-4C4A-B226-9CC5AEA60165Q43474298-8B9676D8-31EE-4EC5-AEA4-62BDC52AE5DBQ44089735-0F27F48E-DD25-47E1-8C9A-E62BD32F4658
P2860
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@en
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@nl
type
label
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@en
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@nl
prefLabel
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@en
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@nl
P2093
P2860
P1476
Methylnaltrexone prevents morp ...... ized placebo-controlled trial.
@en
P2093
P2860
P304
P356
10.1016/S0009-9236(96)90117-4
P407
P577
1996-04-01T00:00:00Z